The adenosine A2A receptor in human sperm: its role in sperm motility and association with


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 01 04 2024
accepted: 13 05 2024
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 14 6 2024
Statut: epublish

Résumé

The involvement of ATP and cAMP in sperm function has been extensively documented, but the understanding of the role of adenosine and adenosine receptors remains incomplete. This study aimed to examine the presence of adenosine A2A receptor (A2AR) and study the functional role of A2AR in human sperm. The presence and localization of A2AR in human sperm were examined by western blotting and immunofluorescence assays. The functional role of A2AR in sperm was assessed by incubating human sperm with an A2AR agonist (regadenoson) and an A2AR antagonist (SCH58261). The sperm level of A2AR was examined by western blotting in normozoospermic and asthenozoospermic men to evaluate the association of A2AR with sperm motility and A2AR with a molecular weight of 43 kDa was detected in the tail of human sperm. SCH58261 decreased the motility, penetration ability, intracellular Ca These results indicate that A2AR is important for human sperm motility and is associated with IVF outcome.

Sections du résumé

Background UNASSIGNED
The involvement of ATP and cAMP in sperm function has been extensively documented, but the understanding of the role of adenosine and adenosine receptors remains incomplete. This study aimed to examine the presence of adenosine A2A receptor (A2AR) and study the functional role of A2AR in human sperm.
Methods UNASSIGNED
The presence and localization of A2AR in human sperm were examined by western blotting and immunofluorescence assays. The functional role of A2AR in sperm was assessed by incubating human sperm with an A2AR agonist (regadenoson) and an A2AR antagonist (SCH58261). The sperm level of A2AR was examined by western blotting in normozoospermic and asthenozoospermic men to evaluate the association of A2AR with sperm motility and
Results UNASSIGNED
A2AR with a molecular weight of 43 kDa was detected in the tail of human sperm. SCH58261 decreased the motility, penetration ability, intracellular Ca
Conclusions UNASSIGNED
These results indicate that A2AR is important for human sperm motility and is associated with IVF outcome.

Identifiants

pubmed: 38872963
doi: 10.3389/fendo.2024.1410370
pmc: PMC11169588
doi:

Substances chimiques

Receptor, Adenosine A2A 0
Pyrazoles 0
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine 0
Adenosine A2 Receptor Agonists 0
Adenosine A2 Receptor Antagonists 0
Pyrimidines 0
Triazoles 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1410370

Informations de copyright

Copyright © 2024 Chen, Xing, Xu, Chen, Xia, Huang, Huang, Hong, Luo, Wang and Wu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Houyang Chen (H)

Reproductive Medical Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.

Genbao Xing (G)

Reproductive Medical Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.

Wenqing Xu (W)

Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Ying Chen (Y)

Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Leizhen Xia (L)

Reproductive Medical Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.

Hua Huang (H)

Reproductive Medical Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.

Jialv Huang (J)

Reproductive Medical Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.

Qing Hong (Q)

Reproductive Medical Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.

Tao Luo (T)

Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.
Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Hao Wang (H)

Department of Urology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Qiongfang Wu (Q)

Reproductive Medical Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Reproductive Health, Nanchang, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH